Stock Update (NYSE:LLY): EU Commission clears Eli Lilly, Novartis deal

[Reuters - UK Focus] – EU antitrust regulators approved U.S. drugmaker Eli Lilly’s $5.4 billion takeover of Swiss peer Novartis’s animal health business on Friday. The European Commission said it was satisfied that . . . → Read More: Stock Update (NYSE:LLY): EU Commission clears Eli Lilly, Novartis deal Similar Articles: Stock Update (NYSE:LLY): Elanco Animal Health, Dow AgroSciences Announce Strategic R&D Agreement Market Update: Eli Lilly & Company (NYSE:LLY) – Lilly to Participate in Morgan Stanley 2014 Global Healthcare Conference Market Update (NYSE:LLY): Lilly Declares Second-Quarter 2014 Dividend